Cannabis Law Report

NOVEMBER 26, 2019

The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards.

Safety 49

Safety Food CBD Oil 49

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Available at: www.fda.gov/media/131878/download.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

AUGUST 30, 2021

I’m excited to join the Travelers Institute for a data-driven discussion,” said Wasserman. With new census data, control of Congress on a knife-edge and redistricting just ahead, there couldn’t be a better time to dive into the numbers.”. Media: Sperry Mylott, 860.277.5075. 22 – “High Risk? smylott@travelers.com.

Programs 81

Programs Data Policy Topical 81

Cannabis Law Report

SEPTEMBER 15, 2021

The FDA is aware of media reports of delta-8 THC products getting consumers “high.” Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans. Findings based on NPDS data do not necessarily reflect the opinions of AAPCC. exposures to any substance(s).

THC 105

THC Pets Events Hemp 105

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Recent data suggest the US science knowledge is about the global average.

Research and Development 112

Research and Development Data THC Clinical Trials 112

Cannabis Law Report

JULY 8, 2021

The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. and are difficult to predict. cbdMD, Inc. John Weston. Director of Investor Relations.

Research and Development 85

Research and Development Pets Cannabinoids eCommerce 85

The Blunt Truth

AUGUST 13, 2019

On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. The FDA is collecting data to fill these gaps. The public hearing attracted over 100 speakers and 2000 participants.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

SpeedWeed

JULY 25, 2021

Here are the applicants and their scores with notable MSO losses in red text: Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media. Copyright © 2021 by CNB Media LLC dba Cannabiz Media Source: Cannabiz Media License Database www.cannabiz.media.

Media 52

Media Data Dispensary Access 52

SpeedWeed

JULY 7, 2021

Here’s how the 282 acres stacked up by license type: Figuring out cultivation size nationally is probably more art than science given the data gaps that exist. Currently, Oklahoma has 7,754 licenses according to the Cannabiz Media License Database – but there is no limit to how much cannabis an Oklahoma cultivator can grow.

Cultivation 52

Cultivation Media Data Compliance 52

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021. Net loss for the six months ended 30 June 2021 was $30.2 million, or $0.79 million) compared with $24.8 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

SpeedWeed

JULY 8, 2021

Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. Ed has managed product, marketing, and sales while overseeing complex multijurisdictional product lines in the securities, corporate, UCC, safety, environmental, and human resource markets. .

Media 52

Media Data Retail Concentrates 52

The Blunt Truth

MAY 26, 2020

In his statement, Commissioner Hahn noted that the FDA was working on: 1) continuing to educate the public on the risks of CBD; 2) seeking reliable data on the safety and benefits of CBD, including opening the public docket on the matter; and 3) monitoring the marketplace for the sale and marketing of unapproved drugs.

CBD 103

CBD Hemp Programs Food 103

SpeedWeed

JULY 6, 2021

Safety data is limited, and testing for CRC contamination is missing—even in legalization states. Many legal and illicit hashmakers now use a ‘color remediation column’—often a steel cylinder (column) packed with a filtration media like sand—during extraction to filter impurities. What is CRC tech? How safe is CRC hash?

Hash 52

Hash Media Extraction Terpenes 52

WeedAdvisor

JULY 21, 2019

The Financial Times explains: “The excitement over cannabis in Colombia has reached fever pitch with some local media reports suggesting the country could supply two-fifths of the world’s marijuana and earn more from it than it does from coal or cut flowers. The checklist is endless, but every box needs to be marked.

Conditions 60

Conditions Seed-To-Sale Compliance Compliance 60

Veriheal

AUGUST 12, 2021

The authors added that in spite of the growing availability and diversity of alternative cannabinoid products like artisanal CBD—as opposed to pharmaceutical CBD—existing studies assessing their efficacy and/or safety are extremely rare. The majority of patients (74%) were Caucasian and more than half (55%) identified as female.

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Miss Marijuana

JUNE 30, 2019

I mean duh, with social media, bosses that don’t understand you have a life and the new Bob Dylan documentary on Netflix – how can anyone doze off and dream anymore? And who doesn’t feel that dark cloud of stress, anxiety and drag get bigger when they’re tossing and turning all night? So what’s next?

Sleep 72

Sleep CBD Clinical Trials Oil 72

Puff Puff Post

FEBRUARY 24, 2020

These results raise safety and efficacy concerns. “Ensuring accurate CBD dosage labelling is important for consumer safety and efficacy,” said Dr. Guy Setton , CEO of GemmaCert Ltd. Media Contact: Hadas Weizman hadas@marcomm.co.il +972(0)54-6077622. TEL AVIV, Israel , Feb.

CBD 52

CBD Safety Pharmaceutical Media 52

Greenspoon Marder Cannabis Law Group Blog

OCTOBER 8, 2019

The Center for Disease Control (CDC), the federal agency that is on the front lines for any threat to public health, works closely with FDA and state health departments to gather data and then communicates risk to the public. When a product has been widely distributed, the news media is used to reach large numbers of people.

Vaping 64

Vaping THC Supply Chain Food 64

Marijuana Lawyer Blog

DECEMBER 7, 2019

And as the epidemic dragged on, news reports covered a notable dip in vape sales, understandably as consumers took a slight step back from vaping until safety could be assured. Since then, data has shown that vaping cannabis sales have stabilized, and even increased market share in a number of states. the week of August 19 to 24.3%

Vaping 52

Vaping Safety Education Dispensary 52

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. Taking CBD can relieve pain.”. “In

THC 52

THC CBD Media Food 52

Cannabis Law Report

JUNE 20, 2022

The findings in this report point to policies and practices that promote and preserve public health and safety, while allowing legal businesses to compete.”. “We are pleased to release this report that highlights the successful launch of Maine’s adult use market,” said OCP Director Erik Gundersen. “The

Programs 52

Programs Policy Consumption Access 52

Cannabis Law Report

JULY 13, 2022

The 2022-23 budget and accompanying tax reform bill will provide significant and immediate relief to cannabis businesses, support equity operators, strengthen enforcement tools against illegal cannabis operators, and protect youth, environmental, and public safety programs funding. Supporting equity. million dollars to-date.

Compliance 52

Compliance Compliance Supply Chain Environment 52

Cannabis Law Report

JANUARY 24, 2022

Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. In 2022, we anticipate reading out interim data from our ongoing Phase 2 clinical trial of GFB-887, as well as initial data from our ongoing Phase 1 study of GFB-024.

Clinical Trials 40

Clinical Trials Research and Development Data Medicine 40

The Cannigma

APRIL 8, 2021

CP: I’m going to say yes and it’s hard to tie this together, but there’s actually some really good animal, and a little bit of human data to support this. I postulate that that is correlated to our endocannabinoid system, which good data is now suggesting, is dysregulated in metabolic syndrome: obesity, diabetes, heart disease.

Medicine 112

Medicine Cannabinoids Cannabis THC 112

Cannabis Law Report

JANUARY 13, 2020

Continue to explore CBDV in autism through a combination of open-label and investigator-led placebo controlled clinical trials with data from one or more of these programs in 2020. Media Enquiries: Sam Brown Inc. media enquiries. Execute NHIE clinical program utilizing an intravenous formulation of cannabidiol. Christy Curran.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Cannabis Law Report

OCTOBER 15, 2021

The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e., New data supporting the use of machine learning and electronic health records to predict DN in patients with diabetes. “In

Clinical Trials 40

Clinical Trials Research and Development Data Patients 40

SpeedWeed

MARCH 7, 2021

In the latest episode of the Cannacurio Podcast from Cannabiz Media, my co-host, Amanda Guerrero, and I discuss license updates coming to the Cannabiz Media License Database, including Oregon cannabis licenses, Louisiana CBD licenses, and Pennsylvania, Ohio, Montana and South Carolina hemp licenses. ‍ Ed Keating : Hi Amanda.

Extraction 52

Extraction Data Hemp Research and Development 52

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g.,

CBD 40

CBD Research and Development Safety Therapy 40

SpeedWeed

APRIL 21, 2021

Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. Ed has managed product, marketing, and sales while overseeing complex multijurisdictional product lines in the securities, corporate, UCC, safety, environmental, and human resource markets. .

Programs 52

Programs Dispensary Oil Cultivation 52

Cannabis Law Report

FEBRUARY 3, 2022

Health and Safety. The safety of our community is of utmost importance to ensure a constructive live event that advances the dynamic advanced design and manufacturing sectors that rely on IME West for new business partnerships and continued education.”. Media Contacts Lauren Lloyd. IMEWest #DiscoverEngineerBuild. PR Director.

Packaging 40

Packaging Events Education Supply Chain 40

The Joint Blog

JULY 25, 2020

Lately, CBD has warranted a huge share of public and media attention for its perceived benefits to health and well-being. FDA is the government agency that ensures the safety and quality of foods, drugs, cosmetics, and other like products marketed in the United States. CBD Legal and Safety Issues An FDA report presented to the U.S.

CBD 33

CBD Clinical Trials Safety Media 33

Cannabis Law Report

DECEMBER 8, 2019

AJEM’s mission is to create, collect, and disseminate credible cannabis research data. United States Food and Drug Administration Center for Food Safety and Applied Nutrition. Scientific data and information about products containing cannabis or cannabis-derived compounds. link] media/128593/download. Cannabis Law J.

Medicine 45

Medicine Research and Development Food Cannabinoids 45

Cannabis Law Report

FEBRUARY 17, 2022

Mycotoxins are contaminants that licensees are required to screen for to uphold public health, safety, and welfare. Mycotoxins are contaminants that licensees are required to screen for to uphold public health, safety, and welfare. There are currently no ISO-accredited Independent Testing Laboratories located on Nantucket.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

SpeedWeed

FEBRUARY 19, 2021

In the latest episode of the Cannacurio Podcast from Cannabiz Media, my co-host, Amanda Guerrero, and I discuss speak with Lews Koski, Chief Operating Officer of Metrc , a leading seed-to-sale track-and-trace technology company for the cannabis and hemp industries. Amanda Guerrero: Welcome to the Cannacurio Podcast, powered by Cannabiz Media.

Seed-To-Sale 52

Seed-To-Sale Environment Supply Chain Data 52

Cannabis Law Report

JULY 20, 2019

Ability to meet the overall health needs of qualified patients and safety of the public. Measure 1, Security plan: The applicant shall provide an acceptable safety and security plan, including staffing and site plan, and a detailed description of proposed security and safety measures, which demonstrates compliance with the rules at N.J.A.C.

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

JULY 23, 2019

It is important that they conduct medical research into the safety and effectiveness of cannabis products through adequate and well-controlled clinical trials. Some states require mandatory warning statements in advertisements for medical cannabis. a playground, recreation centre, library or public park.

Law 40

Law Clinical Trials CBD Edibles 40

SpeedWeed

MAY 25, 2021

Wurzer agreed, saying “I don’t have a ton of good data on this.”. For convenience and fire safety, flick that BIC. Mitchell Colbert is a freelance journalist who has written for Cannabis Now, Hemp Magazine, Green Flower Media, High Times, the Wine Industry Advisor, and other cannabis- and alcohol-focused publications.

Hemp 52

Hemp Vaping Hash Tincture 52